| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |